Efficacy and Safety of Daratumumab-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma - A Systematic Literature Review and Network Meta-analysis

被引：1

作者：

Dimopoulos, Meletios ^{[1
]}

Weisel, Katja ^{[2
]}

Kaufman, Jonathan L. ^{[3
]}

Sonneveld, Pieter ^{[4
]}

Rizzo, Maria ^{[5
]}

Xu, Yingxin ^{[5
]}

Fahrbach, Kyle ^{[5
]}

Gaudig, Maren ^{[6
]}

Slavcev, Mary ^{[7
]}

Lam, Annette ^{[7
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Athens, Greece

[2] Univ Hosp Tuebingen, Tubingen, Germany

[3] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[4] Erasmus MC, Inst Canc, Rotterdam, Netherlands

[5] Evidera, Bethesda, MD USA

[6] Janssen Cilag, Beerse, Belgium

[7] Johnson & Johnson, New Brunswick, NJ USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 01期

关键词：

D O I：

10.1016/j.clml.2017.03.115

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PS-113

引用

页码：E63 / E63

页数：1

共 50 条

[1] EFFICACY OF DARATUMUMAB-BASED REGIMENS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA - A SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS
Dimopoulos, M. A.
Weisel, K.
Kaufman, J.
Sonneveld, P.
Rizzo, M.
Xu, Y.
Fahrbach, K.
Gaudig, M.
Slavcev, M.
Dearden, L.
Lam, A.
[J]. HAEMATOLOGICA, 2017, 102 : 525 - 526
[2] Efficacy and Safety of Daratumumab Based Regimens for Multiple Myeloma: A Systematic Review and Meta-Analysis
Abu Zar, Muhammad
Kamal, Ahmad
Khan, Ali Younas
Malik, Saad Ullah
Malik, Mustafa Nadeem
Rafae, Abdul
Durer, Ceren
Durer, Seren
Selene, Insija Ilyas
Qureshi, Anum
Jose, Jemin Aby
Fazeel, Hafiz Muhammad
Shah, Zunairah
Rehman, Muhammad Adil
Anwer, Faiz
[J]. BLOOD, 2018, 132
[3] Efficacy of Venetoclax Based Regimens in Relapsed Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis
Hashim, Laila
Faisal, Muhammad Salman
Ahmed, Zahoor
Selene, Insija Ilyas
Shahzad, Moazzam
Abdullah, Syed Maaz
Samhouri, Yazan
Yasir, Muhammad
Wahab, Ahsan
Ehsan, Hamid
Neupane, Karun
Anwer, Faiz
Fazal, Salman
[J]. BLOOD, 2020, 136
[4] Role of Daratumumab in Relapsed and Refractory Multiple Myeloma Patients: Meta-Analysis and Literature Review
Abodunrin, Faith O.
Tauseef, Abubakar
Silberstein, Peter
[J]. BLOOD, 2021, 138
[5] Daratumumab-Based Regimens with Prior Carfilzomib in Patients with Relapsed Refractory Multiple Myeloma (RRMM)
Tungesvik, Alexandre
Huang, Jessica
Sudalagunta, Praneeth
Dimaggio, Elizabeth
De Avila, Gabe
Tandon, Ankita
Nelson, Rebeccah
Olson, Laura
Tobon, Katherine
Shain, Kenneth
Brayer, Jason
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S327 - S328
[6] Systematic Literature Review and Network Meta-Analysis of Treatments for Relapsed/Refractory Multiple Myeloma Patients
Van Beurden-Tan, Chrissy H. Y.
Franken, Margreet
Blommestein, Hedwig
Uyl-De Groot, Carin A.
Sonneveld, Pieter
[J]. BLOOD, 2016, 128 (22)
[7] Systematic Literature Review and Network Meta-Analysis of Treatments for Relapsed/Refractory Multiple Myeloma Patients
van Beurden-Tan, Chrissy H. Y.
Franken, Margreet
Blommestein, Hedwig
Uyl-de Groot, Carin
Sonneveld, Pieter
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E144 - E144
[8] Daratumumab-based induction therapy for multiple myeloma: A systematic review and meta-analysis
Chong, Lip Leong
Soon, Yu Yang
Soekojo, Cinnie Yentia
Ooi, Melissa
Chng, Wee Joo
de Mel, Sanjay
[J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 159
[9] The efficacy and safety of triplet regimens based on pomalidomide and dexamethasone for treatment of relapsed/refractory multiple myeloma: a systematic review and meta-analysis
Liao, K-Y
Liu, Y.
Xiong, H.
Chen, X-M
Zhang, X-W
Huang, C-L
[J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (21) : 8087 - 8097
[10] Efficacy and safety of selinexor-based regimens for relapsed/refractory multiple myeloma: a systematic review of literature
Masood, Adeel
Iqbal, Qamar
Ehsan, Hamid
Davis, James A.
Hansen, Doris K.
Hashmi, Hamza
[J]. ANNALS OF HEMATOLOGY, 2022, 101 (12) : 2601 - 2610

← 1 2 3 4 5 →